Your browser doesn't support javascript.
loading
Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr, Mark T; Beebe, Elyse A; Hudson, Thomas E; Argilla, David; Huang, Po-Wei D; Reese, Valerie A; Fox, Christopher B; Reed, Steven G; Coler, Rhea N.
Afiliação
  • Orr MT; Infectious Disease Research Institute, Seattle, WA 98102, USA; Department of Global Health, University of Washington, Seattle, WA 98105, USA. Electronic address: Mark.orr@idri.org.
  • Beebe EA; Infectious Disease Research Institute, Seattle, WA 98102, USA.
  • Hudson TE; Infectious Disease Research Institute, Seattle, WA 98102, USA.
  • Argilla D; Infectious Disease Research Institute, Seattle, WA 98102, USA.
  • Huang PW; Infectious Disease Research Institute, Seattle, WA 98102, USA.
  • Reese VA; Infectious Disease Research Institute, Seattle, WA 98102, USA.
  • Fox CB; Infectious Disease Research Institute, Seattle, WA 98102, USA; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
  • Reed SG; Infectious Disease Research Institute, Seattle, WA 98102, USA; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
  • Coler RN; Infectious Disease Research Institute, Seattle, WA 98102, USA; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
Vaccine ; 33(48): 6570-8, 2015 Nov 27.
Article em En | MEDLINE | ID: mdl-26541135

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Células Th1 / Vacinas contra a Tuberculose / Células Th17 Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Células Th1 / Vacinas contra a Tuberculose / Células Th17 Idioma: En Ano de publicação: 2015 Tipo de documento: Article